Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

Eric M. Reiman, Kewei Chen, Xiaofen Liu, +14

Proceedings of the National Academy of Sciences

Fibrillar Amyloid-β BurdenNeurochemical BiomarkersGeriatric NeurologyAlzheimer's DiseaseNeurology +19

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Jessica B. Langbaum, Kewei Chen, Wendy Lee, +9

NeuroImage

Positron Emission TomographyNeuroimaging BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseHealth Sciences +12

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

Jason J. Corneveaux, Amanda Myers, April N. Allen, +25

Human Molecular Genetics

Cr1 SnpsAlzheimer's DiseaseAce SnpsDementiaGenetics +13

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

Adam Fleisher, Kewei Chen, Yakeel T. Quiroz, +20

The Lancet Neurology

Neurodegenerative DiseasesAlzheimer's DiseaseFlorbetapir Pet AnalysisBiomarkersAmyloid-β Deposition +6

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, +2419

JAMA

Activity Descriptor Identification for Oxygen Reduction on Platinum-Based Bimetallic Nanoparticles: <i>In Situ</i> Observation of the Linear Composition–Strain–Activity Relationship

Qingying Jia, Wentao Liang, Michael K. Bates, +3

ACS Nano

Activity Descriptor IdentificationPt-co Alloy NanoparticlesEngineeringMetal NanoparticlesNanoheterogeneous Catalysis +17

Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred

Adam Fleisher, Kewei Chen, Yakeel T. Quiroz, +20

JAMA Neurology

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Kewei Chen, Jessica B. Langbaum, Adam Fleisher, +14

NeuroImage

Probable AlzheimerAlzheimer's DiseaseAgingDisease Neuroimaging InitiativeDementia +9

Characterizing Alzheimer's disease using a hypometabolic convergence index

Kewei Chen, Napatkamon Ayutyanont, Jessica B. Langbaum, +17

NeuroImage

Alzheimer's DiseaseDementiaVascular DementiaHypometabolic Convergence IndexNeurology +4

Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region

Kewei Chen, Auttawut Roontiva, Pradeep Thiyyagura, +15

Journal of Nuclear Medicine